Stock Market News

Indian Drug Regulator's Sec Committee Has Given Conditional Approval For Merck's Covid-19 Pill Molnupiravir - Cnbc-Tv18 (Corrects To Clarify Drug Regulator's Panel)

January 07, 2022 at 10:01 am

CORRECTED-INDIAN DRUG REGULATOR'S SEC COMMITTEE HAS GIVEN CONDITIONAL APPROVAL FOR MERCK'S COVID-19 PILL MOLNUPIRAVIR - CNBC-TV18 (CORRECTS TO CLARIFY DRUG REGULATOR'S PANEL)

Headlines

Strategy: Is China becoming unattractive again with Trump and Vance?

Wall Street: Soxx plunges to its lowest level since 03/2022

July 17, 2024 at 10:55 pm

Discover Financial quarterly profit jumps on higher interest income

July 17, 2024 at 10:41 pm

Wheat Futures Climb on Hopes for Better Export Sales -- Daily Grain Highlights

July 17, 2024 at 08:47 pm

Nymex Overview : Crude Oil Contracts Lead Petroleum Futures Higher -- OPIS

July 17, 2024 at 05:50 pm

Global markets live: Adidas, TSMC, Vale, HSBC, J&J...

July 17, 2024 at 05:24 pm

Apax, Bain and CVC exploring potential bids for SoftwareOne, sources say

July 17, 2024 at 05:10 pm

Gold Futures Glitter on Record High With Further Gains in Sight -- 2nd Update

July 17, 2024 at 05:06 pm

For stocks, is AI the Emperor's new clothes?: McGeever

July 17, 2024 at 04:57 pm

CAC40: close to equilibrium, erases part of losses

July 17, 2024 at 04:55 pm

All our articles

Stock Market News

Indian Drug Regulator's Sec Committee Has Given Conditional Approval For Merck's Covid-19 Pill Molnupiravir - Cnbc-Tv18 (Corrects To Clarify Drug Regulator's Panel)

Headlines

Most Read News